Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IRAK2 Antibodies:
anti-Mouse (Murine) IRAK2 Antibodies:
anti-Rat (Rattus) IRAK2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal IRAK2 Primary Antibody for EIA, IF - ABIN500042
Cao, Henzel, Gao: IRAK: a kinase associated with the interleukin-1 receptor. in Science (New York, N.Y.) 1996
Show all 4 references for ABIN500042
Human Polyclonal IRAK2 Primary Antibody for EIA, IF - ABIN500038
Hardy, ONeill: The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. in The Journal of biological chemistry 2004
Show all 4 references for ABIN500038
Mouse (Murine) Polyclonal IRAK2 Primary Antibody for EIA, WB - ABIN500040
Muzio, Ni, Feng, Dixit: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. in Science (New York, N.Y.) 1997
Show all 4 references for ABIN500040
Human Polyclonal IRAK2 Primary Antibody for WB - ABIN4327504
Kim, Cha, Kang, Lee, Lee, Park, Bae, Song, Im: Corosolic acid ameliorates acute inflammation through inhibition of IRAK-1 phosphorylation in macrophages. in BMB reports 2016
IRAK2 L392V showed intact binding to, but impaired ubiquitination of, tumor necrosis factor (show TNF Antibodies) receptor-associated factor 6, a vital step in signal transduction
This for the first time implicates human IRAK2 in a human disease and highlights the R214G IRAK2 variant as a potential novel and broadly applicable biomarker for disease or as a therapeutic intervention point.
Human miR (show MLXIP Antibodies)-373 is silenced by histone modification in lung cancer cells and is a negative regulator of the mesenchymal phenotype through downstream IRAK2 and LAMP1 (show LAMP1 Antibodies) target genes.
Results suggest that D431E-IRAK2 (interleukin-1 receptor-associated kinase-2) increases NF-kappaB (show NFKB1 Antibodies) activation by promoting TRAF6 (show TRAF6 Antibodies) ubiquitination by enhancing TNF Receptor-Associated Factor 6 (TRAF6 (show TRAF6 Antibodies))-IRAK2 interaction.
These findings demonstrate an unexpected linkage of the innate immunity machinery to unfolded protein response signaling, revealing IRAK2 as a novel amplifier of the IRE1 (show ERN1 Antibodies) pathway.
Human interleukin-1 receptor-associated kinase-2 is essential for Toll (show TLR4 Antibodies)-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha (show TNF Antibodies).
analysis of differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1 (show IRAK1 Antibodies)) and IRAK-2 by microRNA-146a and NF-kappaB (show NFKB1 Antibodies) in stressed human astroglial cells and in Alzheimer disease
Our data show that interleukin-1R-associated kinase 2 is a novel and critical component of TGFbeta (show TGFB1 Antibodies) signaling.
the crystal structure of the MyD88 (show MYD88 Antibodies)-IRAK4 (show IRAK4 Antibodies)-IRAK2 death domain (DD) complex, which surprisingly reveals a left-handed helical oligomer that consists of 6 MyD88 (show MYD88 Antibodies), 4 IRAK4 (show IRAK4 Antibodies) and 4 IRAK2 DDs
CTCF (show CTCF Antibodies) plays a major role in IRAK2 transcription; EMSA revealed a CTCF (show CTCF Antibodies)-binding site within the mouse Irak2 promoter
Our results establish that the IRAK2-TRAF6 (show TRAF6 Antibodies) interaction is rate limiting for the late, but not the early phase of cytokine production in bone marrow-derived macrophages and plasmacytoid dendritic cells
IRAK2 plays a key role in the TLR9 (show TLR9 Antibodies)-mediated transcriptional regulation of Irak-m (show IRAK3 Antibodies) expression by sustaining activation of PKD1 (show PKD1 Antibodies) and NF-kappaB (show NFKB1 Antibodies)
IRAK-2 mediates pathology in a CD4 T cell specific manner by promoting Th17 cell development through enhancement of IL-1beta-induced activation of transcription factors RORgammat and BATF.
the kinase activity of IRAK2 is required for the optimal activation of mitogen-activated protein kinase (show MAPK1 Antibodies) signaling, which regulates cytokine and chemokine (show CCL1 Antibodies) production at posttranscriptional levels.
IRAK2 is a negative regulator of Toll (show TLR4 Antibodies)-like receptor (TLR)9 (show TLR9 Antibodies)-induced interferon (show IFNA Antibodies) production in plasmacytoid dendritic cells.
Alternative splicing of the Irak2 gene in mice will generate agonistic or antagonistic Irak2 isoforms, which is likely to have consequences for the regulation of Toll (show TLR4 Antibodies)-like receptors signaling.
TRAF6 (show TRAF6 Antibodies) and interleukin receptor-associated kinase 2 are novel binding partners for PS1 (show PSEN1 Antibodies), and IL-1R1 is a new substrate for presenilin-dependent gamma-secretase cleavage
These results reveal that IRAK2 is required for LPS (show TLR4 Antibodies)-mediated post-transcriptional control of cytokine and chemokine (show CCL1 Antibodies) expression, which plays an essential role in TLR4 (show TLR4 Antibodies)-induced septic shock.
Data demonstrate that IRAK-2 is an essential component of the early TLR response in MOLF/Ei mice and show a distinct pathway of p38 (show CRK Antibodies) and NF-kappaB (show NFKB1 Antibodies) activation in this model organism.
IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB.
interleukin-1 receptor associated kinase-2
, interleukin-1 receptor-associated kinase-like 2
, interleukin-1 receptor-associated kinase 2c